Arlington Research Center
Arlington, Texas 76011-3800
0 studies enrolling now · 21 studies all time
What they study most
Acne, Acne Inversa, Acne Vulgaris, Alopecia Areata, Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis, Unspecified, Diabetic Foot Ulcers, Eczema, Eczema, Atopic, Foot Wounds, Molluscum Contagiosum
Studies at this site
- Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne — Running, not enrolling
- A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
- A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata — Running, not enrolling
- A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling
- A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis — Completed
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo. — Stopped early
- The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. — Stopped early
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
- Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis — Completed
- A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection — Stopped early
- A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3) — Completed
- Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris — Completed
- Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
- Sarecycline Truncal Acne Safety and Efficacy Response — Completed
- A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa — Completed
- Mirvaso in Use Study — Completed
- Cantharidin Application in Molluscum Patients-1 — Completed
- The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis — Completed
- Safety Follow-Up to HP 802-247-09-015 — Completed
- Dose Finding Study of HP802-247 in Venous Leg Ulcers — Completed
- Santyl vs. Sharp Debridement of Diabetic Foot Wounds — Completed